Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy.
about
Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Tocilizumab in JIA patients wh ...... umour necrosis factor therapy.
@en
Tocilizumab in JIA patients wh ...... umour necrosis factor therapy.
@nl
type
label
Tocilizumab in JIA patients wh ...... umour necrosis factor therapy.
@en
Tocilizumab in JIA patients wh ...... umour necrosis factor therapy.
@nl
prefLabel
Tocilizumab in JIA patients wh ...... umour necrosis factor therapy.
@en
Tocilizumab in JIA patients wh ...... umour necrosis factor therapy.
@nl
P1476
Tocilizumab in JIA patients wh ...... tumour necrosis factor therapy
@en
P2093
M Katsicas
P2888
P304
P356
10.1186/1546-0096-9-S1-P186
P433
P577
2011-09-14T00:00:00Z
P6179
1014788182